3-methylglutaconic acid has been researched along with Brain Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Essa, M; Al-Shamsan, L; Bakheet, S; Ozand, PT; Patay, Z; Powe, J | 1 |
| Andrieu, A; Bildstein, G; Chateauneuf, R; Delisle, B; Divry, P; Laurent-Pellegrin, M; Netter, JC; Petrus, M | 1 |
2 other study(ies) available for 3-methylglutaconic acid and Brain Diseases
| Article | Year |
|---|---|
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Glutarates; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Nervous System Diseases; Optic Atrophy; Paraplegia; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
[Hypertrophic cardiomyopathy and neonatal encephalopathy associated with 3-methylglutaconic aciduria].
Topics: Autopsy; Brain Diseases; Cardiomyopathy, Hypertrophic; Female; Glutarates; Humans; Infant, Newborn; Myocardium; Occipital Lobe | 1987 |